Inspire Medical Systems Management
Management criteria checks 4/4
Inspire Medical Systems' CEO is Tim Herbert, appointed in Nov 2007, has a tenure of 17.08 years. total yearly compensation is $7.49M, comprised of 9.2% salary and 90.8% bonuses, including company stock and options. directly owns 0.61% of the company’s shares, worth $34.41M. The average tenure of the management team and the board of directors is 4.4 years and 5.4 years respectively.
Key information
Tim Herbert
Chief executive officer
US$7.5m
Total compensation
| CEO salary percentage | 9.2% |
| CEO tenure | 17.1yrs |
| CEO ownership | 0.6% |
| Management average tenure | 4.4yrs |
| Board average tenure | 5.4yrs |
Recent management updates
Recent updates
Getting In Cheap On Inspire Medical Systems, Inc. (NYSE:INSP) Might Be Difficult
Dec 11
Inspire Medical Systems: Getting Cheaper But Not There Yet
Nov 23Inspire Medical Systems, Inc. Just Recorded A 894% EPS Beat: Here's What Analysts Are Forecasting Next
Nov 07A Look At The Intrinsic Value Of Inspire Medical Systems, Inc. (NYSE:INSP)
Oct 31Is Now The Time To Look At Buying Inspire Medical Systems, Inc. (NYSE:INSP)?
Oct 03After Leaping 39% Inspire Medical Systems, Inc. (NYSE:INSP) Shares Are Not Flying Under The Radar
Aug 08Is Inspire Medical Systems, Inc. (NYSE:INSP) Trading At A 39% Discount?
Jul 17At US$162, Is It Time To Put Inspire Medical Systems, Inc. (NYSE:INSP) On Your Watch List?
Jun 22Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors
May 09Inspire Medical Systems: A Potential Example Of Market Mispricing
Apr 05Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate
Mar 27Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?
Mar 06Inspire Medical: A Good Night Sleep
Feb 08Inspire Medical Systems: Time To Wake Up
Nov 17Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth
Oct 25Inspire Medical Systems: Excellent Execution And Reset Valuation
Aug 17Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment
Jul 19Inspire Medical Systems: Valuation, Sentiment, Fundamental Factors Call For Re-Rating
Jun 15CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$33m |
| Jun 30 2024 | n/a | n/a | US$6m |
| Mar 31 2024 | n/a | n/a | -US$16m |
| Dec 31 2023 | US$7m | US$690k | -US$21m |
| Sep 30 2023 | n/a | n/a | -US$33m |
| Jun 30 2023 | n/a | n/a | -US$41m |
| Mar 31 2023 | n/a | n/a | -US$44m |
| Dec 31 2022 | US$6m | US$645k | -US$45m |
| Sep 30 2022 | n/a | n/a | -US$50m |
| Jun 30 2022 | n/a | n/a | -US$44m |
| Mar 31 2022 | n/a | n/a | -US$43m |
| Dec 31 2021 | US$1m | US$620k | -US$42m |
| Sep 30 2021 | n/a | n/a | -US$47m |
| Jun 30 2021 | n/a | n/a | -US$47m |
| Mar 31 2021 | n/a | n/a | -US$57m |
| Dec 31 2020 | US$5m | US$506k | -US$57m |
| Sep 30 2020 | n/a | n/a | -US$59m |
| Jun 30 2020 | n/a | n/a | -US$57m |
| Mar 31 2020 | n/a | n/a | -US$41m |
| Dec 31 2019 | US$3m | US$440k | -US$33m |
| Sep 30 2019 | n/a | n/a | -US$29m |
| Jun 30 2019 | n/a | n/a | -US$25m |
| Mar 31 2019 | n/a | n/a | -US$24m |
| Dec 31 2018 | US$3m | US$418k | -US$22m |
| Sep 30 2018 | n/a | n/a | -US$21m |
| Jun 30 2018 | n/a | n/a | -US$21m |
| Mar 31 2018 | n/a | n/a | -US$20m |
| Dec 31 2017 | US$600k | US$380k | -US$18m |
Compensation vs Market: Tim's total compensation ($USD7.49M) is about average for companies of similar size in the US market ($USD7.98M).
Compensation vs Earnings: Tim's compensation has been consistent with company performance over the past year.
CEO
Tim Herbert (61 yo)
17.1yrs
Tenure
US$7,490,775
Compensation
Mr. Timothy P. Herbert, also known as Tim, has been Chief Executive Officer, President and Director of Inspire Medical Systems, Inc. since November 2007 and has been its Chairman since May 2, 2024. He is t...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 17.1yrs | US$7.49m | 0.61% $ 34.4m | |
| Chief Financial Officer | 10.6yrs | US$2.30m | 0.10% $ 5.7m | |
| Chief Commercial Officer | 5.9yrs | US$2.26m | 0.0023% $ 131.0k | |
| Chief Medical Officer | 1.4yrs | US$211.35k | 0.0031% $ 176.2k | |
| Chief Strategy Officer | 1.4yrs | US$2.10m | 0% $ 0 | |
| Chief Technology Officer | 2.6yrs | US$2.10m | 0.029% $ 1.6m | |
| Vice President of Investor Relations | no data | no data | no data | |
| Senior VP | 3.9yrs | US$2.69m | 0.0044% $ 246.3k | |
| Chief People Officer | less than a year | no data | no data | |
| Senior Vice President of U.S. Sales | 4.9yrs | no data | no data | |
| Executive VP & MD of Europe | 4.9yrs | no data | no data | |
| Director of Financial Reporting | no data | no data | no data |
4.4yrs
Average Tenure
56yo
Average Age
Experienced Management: INSP's management team is considered experienced (4.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 17.1yrs | US$7.49m | 0.61% $ 34.4m | |
| Independent Director | 16.9yrs | US$235.88k | 0.068% $ 3.9m | |
| Independent Director | 16.4yrs | US$238.38k | 0.069% $ 3.9m | |
| Independent Director | 7.9yrs | US$248.38k | 0.085% $ 4.8m | |
| Independent Director | 4.2yrs | US$243.38k | 0.0060% $ 336.1k | |
| Lead Independent Director | 5.4yrs | US$243.38k | 0.012% $ 673.3k | |
| Independent Director | 4.4yrs | US$238.38k | 0.0050% $ 282.4k | |
| Independent Director | less than a year | US$271.56k | 0% $ 0 | |
| Independent Director | 2.4yrs | US$235.88k | 0.0022% $ 126.0k |
5.4yrs
Average Tenure
65yo
Average Age
Experienced Board: INSP's board of directors are considered experienced (5.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 03:36 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Inspire Medical Systems, Inc. is covered by 24 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Polark | Baird |
| David Rescott | Baird |
| Ravi Misra | Berenberg |